Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.
Crinò L, Ahn MJ, De Marinis F, Groen HJ, Wakelee H, Hida T, Mok T, Spigel D, Felip E, Nishio M, Scagliotti G, Branle F, Emeremni C, Quadrigli M, Zhang J, Shaw AT. Crinò L, et al. Among authors: scagliotti g. J Clin Oncol. 2016 Aug 20;34(24):2866-73. doi: 10.1200/JCO.2015.65.5936. Epub 2016 Jul 18. J Clin Oncol. 2016. PMID: 27432917 Clinical Trial.
Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872.
Planting AS, Ardizzoni A, Estapé J, Giaccone G, Scagliotti G, Splinter TA, Kirkpatrick A, Dalesio O, McVie JG. Planting AS, et al. Among authors: scagliotti g. Cancer Chemother Pharmacol. 1991;28(2):145-6. doi: 10.1007/BF00689706. Cancer Chemother Pharmacol. 1991. PMID: 1647894 Free article.
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
Scagliotti GV, Ricardi U, Crinó L, Maranzano E, De Marinis F, Morandi MG, Meacci L, Marangolo M, Emiliani E, Rosti G, Figoli F, Bolzicco G, Masiero P, Gentile A, Tonato M. Scagliotti GV, et al. Cancer Chemother Pharmacol. 1996;38(6):561-5. doi: 10.1007/s002800050527. Cancer Chemother Pharmacol. 1996. PMID: 8823499 Clinical Trial.
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
Crinò L, Scagliotti G, Marangolo M, Figoli F, Clerici M, De Marinis F, Salvati F, Cruciani G, Dogliotti L, Pucci F, Paccagnella A, Adamo V, Altavilla G, Incoronato P, Trippetti M, Mosconi AM, Santucci A, Sorbolini S, Oliva C, Tonato M. Crinò L, et al. Among authors: scagliotti g. J Clin Oncol. 1997 Jan;15(1):297-303. doi: 10.1200/JCO.1997.15.1.297. J Clin Oncol. 1997. PMID: 8996156 Clinical Trial.
Chemotherapy of non-small cell lung cancer.
Scagliotti GV, Crinò L. Scagliotti GV, et al. Monaldi Arch Chest Dis. 1997 Jun;52(3):287-95. Monaldi Arch Chest Dis. 1997. PMID: 9270260 Review. No abstract available.
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Giaccone G, Splinter TA, Debruyne C, Kho GS, Lianes P, van Zandwijk N, Pennucci MC, Scagliotti G, van Meerbeeck J, van Hoesel Q, Curran D, Sahmoud T, Postmus PE. Giaccone G, et al. Among authors: scagliotti g. J Clin Oncol. 1998 Jun;16(6):2133-41. doi: 10.1200/JCO.1998.16.6.2133. J Clin Oncol. 1998. PMID: 9626213 Clinical Trial.
460 results